GHK-Cu in skin and hair studies
Here the human results concern appearance, skin-building materials and a hair mixture. Their specificity is more interesting than the promise of general rejuvenation.
The skin findings
The review of GHK and skin regeneration describes small human topical studies reporting improvements in laxity, fine lines, wrinkle depth and skin density. GHK-Cu also stimulated production of collagen and other supporting materials in cell work. The outcomes concern skin; a sports-injury benefit remains unestablished.
GHK consists of glycine, histidine and lysine. In GHK-Cu, those three amino acids bind copper. Free GHK and its copper complex have to be distinguished when discussing a paper, because the form can affect the result.
I’ll happily discuss the skin measurements. Claims that every tissue must therefore become younger demand far more evidence.
Getting through skin
Delivery is a central difficulty in the 2025 review of topical GHK. The outer skin barrier restricts passage of the native peptide, and researchers have investigated chemical modifications, carriers and microneedle pretreatment. An ingredient’s presence leaves the amount reaching its target unresolved.
The study of copper penetration through removed human skin measured copper passing into and through the tissue, with some retained there. It was an ex vivo experiment: human skin outside a living person. Measuring copper in those layers also differs from demonstrating intact GHK-Cu throughout the body.
Delivery is the first obstacle I’d want solved. It determines how close an impressive cell experiment can get to the practical question about a cream.
The hair trial used a mixture
The six-month trial involving forty-five men with androgenetic alopecia tested a complex of GHK and 5-aminolevulinic acid against placebo. Hair counts increased more in the active groups, and no adverse events were reported in any group.
This is a controlled human efficacy result worth discussing. It concerns a GHK-containing combination, with hair counts as the outcome. Crediting GHK-Cu alone would change both the treatment and the claim. I’d credit the combination here; separating its ingredients would require another comparison.
Cellular gene activity
The review of gene-expression data links GHK to changes in pathways associated with repair, antioxidant activity and DNA maintenance. These are analyses of cellular gene activity, rather than demonstrated improvements in an athlete’s strength or recovery.
The breadth is intriguing. My confidence falls when that breadth is used to make a single claim about the whole body. A functional benefit needs a measured functional outcome, and systemic GHK-Cu lacks validated human pharmacokinetic evidence in these sources.
The topical review offers a more grounded set of questions about the chemical form, formulation and tissue being studied.
User accounts, safety and sport
People describe firmer or moister skin, softer lines, smoother texture and reduced hair shedding. Others report redness, dryness, irritation, breakouts or uneven pigmentation. Injectable accounts are less well supported. These are anecdotal accounts, not clinical evidence, and use of several skin products makes causes especially difficult to separate.
Long-term systemic effects, including questions about copper handling and copper–zinc balance, remain unresolved. GHK-Cu has no FDA-approved therapeutic indication. Its cosmetic use on skin provides no approval for injectable or systemic use.
GHK-Cu is not named like BPC-157 or TB-500 in the sport sources gathered here, but wider rules for non-approved substances may apply. Clearance depends on the current rules and the relevant anti-doping body. The comparison puts the skin results alongside the other compounds’ very different outcomes.